| Literature DB >> 26185007 |
Catalin V Maftei1, Elena Fodor1, Peter G Jones2, Matthias Freytag2, M Heiko Franz3, Gerhard Kelter4, Heinz-Herbert Fiebig4, Matthias Tamm5, Ion Neda6.
Abstract
This work presents the synthesis, characterization and application of eleven new gold (I) complexes 13-23 with 1,2,4-oxadiazole-containing N-heterocyclic carbene (NHC) ligands and of the NHC silver(I) complex 24. The 1,2,4-oxadiazole unit, which can be found in a variety of biologically active natural products such as phidianidines or quisqualic acid, was incorporated, along with a variety of other biologically active moieties (anthracene, indole, 2-pyridine, 2,3,4,5-tetra-O-acetyl-D-glucopyranose, quincorine and quincoridine), in order to change the lipophilicity of the complexes, so that the transport of the active units (M-NHC) though the cell wall barrier is facilitated. The biological activity of the complexes was investigated. In vitro assessment of anti-tumor activity in a panel of 12 human tumor cell lines by a monolayer assay revealed impressive potency (mean IC50 < 0.1 μM) and tumor selectivity for 6 compounds, with individual IC50 values in the low nanomolar range. The solid state structures of compounds 13, 14, 15, 17, 18, 19 and 24 were determined by X-ray diffraction analyses.Entities:
Keywords: 1,2,4-Oxadiazoles; Anti-tumor activity; Bioisosters; Gold-NHC; Natural product analogs; Silver-NHC
Mesh:
Substances:
Year: 2015 PMID: 26185007 DOI: 10.1016/j.ejmech.2015.06.053
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514